(Q77565316)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

New treatments for breast cancer: breakthroughs for patient care or just steps in the right direction? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

A Goldhirsch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A S Coates

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Castiglione-Gertsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

R D Gelber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

973-976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008436810268

7 January 2021

Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008436810268

7 January 2021

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008436810268

7 January 2021

Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008436810268

7 January 2021

Identifiers

DOI

10.1023/A:1008436810268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818070%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference